BioMarin Pharmaceutical Investor Relations Material
Latest events
M&A Announcement
BioMarin Pharmaceutical
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from BioMarin Pharmaceutical Inc
Access all reports
BioMarin Pharmaceutical Inc is a biotechnology company focused on developing and commercializing therapies for rare genetic diseases. Its research and product development efforts target conditions with limited treatment options, primarily in the fields of enzyme replacement and gene therapy. The company serves healthcare providers and patients worldwide through approved treatments and scientific initiatives. The company is headquartered in San Rafael, California, and its shares are listed on the NASDAQ.
Key slides for BioMarin Pharmaceutical Inc
Q1 2025
BioMarin Pharmaceutical Inc
Q1 2025
BioMarin Pharmaceutical Inc
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
BMRN
Country
🇺🇸 United States